CLINICAL_TRIALS
trial_result
· 2021-05-21
Clinical Trial Update: Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy [Phase 2]
Summary
Phase 2 clinical trial evaluating RIvaroxaban for preventing venous thromboembolism after knee arthroscopy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Padova | Conditions: Venous Thromboembolism, Haemorrhage | Phase 2 | Status: COMPLETED | Results posted: 2021-05-21